Genepeutic Bio

Genepeutic Bio is a pioneering biotechnology company based in Thailand, dedicated to the development and manufacturing of advanced cell and gene therapies. The company operates the first GMP-certified cell therapy manufacturing facility in Thailand, specifically designed to produce CAR-T cell treatments. Their primary focus is on providing affordable and accessible advanced therapies for cancer patients in Southeast Asia, starting with hematologic malignancies. Genepeutic Bio's lead candidate is an autologous anti-CD19 CAR-T cell therapy currently in clinical development for B-cell acute lymphoblastic leukemia and B-cell lymphoma. By leveraging local manufacturing capabilities, the company aims to significantly reduce the cost and turnaround time for these life-saving treatments. They maintain strong collaborative ties with Chulalongkorn University and other leading medical institutions to drive innovation in the regional biotech sector.